Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

VPM-1002 shows favorable preclinical and early clinical profile for the treatment of bladder cancer

April 15, 2014

Novel sequencing method developed for the GBA gene

April 15, 2014

Novel potent dual kinase EGFR inhibitor synthesized at Innova Pharmaceuticals

April 15, 2014

CellCollector may improve circulating tumor cell collection for breast cancer monitoring

April 15, 2014

Clinical data demonstrate the feasibility of roniciclib in SCLC and ovarian cancer

April 15, 2014

Improved detection of localized prostate cancer with technetium Tc 99m trofolastat

April 14, 2014

GlaxoSmithKline presents promising preclinical data for GSK-2878175

April 14, 2014

Sofosbuvir/GS-5816 gives SVR12 rates > 90% across all HCV genotypes

April 14, 2014

Preliminary data reported for clinical study of UX-003 in mucopolysaccharidosis type VII

April 14, 2014

Selvita's novel dual Mnk1/2 inhibitors show potential in preclinical models of cancer

April 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...